Expert Systems Accelerating Preclinical Research Across Animal Disease Models

Expert Systems Accelerating Preclinical Research Across Animal Disease Models

Genetic tools for next-generation animal models for preclinical research

RELEASE DATE
03-Aug-2020
REGION
Global
Research Code: D94D-01-00-00-00
SKU: HC03322-GL-TR_24614
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03322-GL-TR_24614

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This study provides insights across recent advances across the use of animal disease models in preclinical research.It encompasses the following aspects:
Technology roadmap, market trends, capabilities, and targeted application
Stakeholder activities, influence, industry initiatives
Investment environment and funding support
Industry evolution and business analytics
Technology benchmarking for smart decisions

Table of Contents

1.1 Research Focus

1.2 Research Scope

1.3 Analysis Framework

1.4 Research Methodology

2.1 Technology Expertise

2.2 Key Discussion Points

2.3 Overview of Animal Disease Models

2.4 Translational Value of Animal Models

2.5 Preclinical Animal Testing

2.6 Optimal Selection of Species

3.1 Emerging Opportunities for Animal Models

3.2 Animal Models Used in Research

3.3 Animal Species Used in Biomedical Research

3.4 Genetically Engineered Models

3.5 Genome engineering in animal models

3.6 Xenograft Animal Models

3.7 Animal Types in preclinical Research

3.8 Health Standards in Animal Models

3.9 Major Therapeutic Areas

4.1 Preclinical Disease Models Adoption Impact

4.2 Macro to Micro Visioning and Implications

4.3 Summary of Key Industry Drivers

4.4 Summary of Key Industry Challenges

4.5 Summary of Key Market Drivers and Restraints

4.6 Mapping of Key Market Drivers and Restraints

4.7 Technology Transfer Assessment and Perceptions

4.8 Open Innovation Avenues in preclinical disease models

5.1 Technology Maturity Level and Description

5.2 Roadmap Tapping into Technology Synergy

5.3 Business Model Hybridization

5.4 Approaches Driving Preclinical Disease Models

5.5 Technology Synergy Reshaping Value Chain

5.6 Future Perspective of Animal Disease Models

6.1 Funding and Investment Models and Adoption

6.2 Funding Contribution Focus

6.3 Preclinical Research Funding Trends

6.4 Private Investment Distribution by Type

6.5 Public Funding Distribution by Type

6.6 Public and Private Funding by Region

6.7 Public and Private Funding to Notice

7.1 Key Future Industry Trends

7.2 Levers for Growth in the Preclinical Space

7.3 Industry Dynamics in Preclinical Discovery

7.4 Regional Adoption Potential

7.5 Growth Opportunity Assessment

8.1 Main Innovators in Animal Disease Models

8.2 Study-ready knockout Mice

8.3 Optogenetics and Expression Systems

8.4 Genome Editing Techniques

8.5 Animal Models as a Service

8.6 Transgenic Mice Platforms

8.7 Syngeneic Cell Lines and Xenografts

8.8 Genetically Engineered Rodents

8.9 Precision Genomics Models

9.1 Key Industry Influencers

9.2 Key Industry Innovators

9.3 Key Industry Developers

9.4 Key Industry Referents

9.5 Key Industry Exemplars

Legal Disclaimer

This study provides insights across recent advances across the use of animal disease models in preclinical research.It encompasses the following aspects: Technology roadmap, market trends, capabilities, and targeted application Stakeholder activities, influence, industry initiatives Investment environment and funding support Industry evolution and business analytics Technology benchmarking for smart decisions
More Information
No Index No
Podcast No
Author Cecilia Van Cauwenberghe
Industries Healthcare
WIP Number D94D-01-00-00-00
Is Prebook No